.. Impact-de-la-l-lysine-sur-la-sécrétion-de-cortisol, 75 3. Points forts et points faibles de l'étude, p.76

?. Contesse, V. Reznik, Y. Duparc, C. Perraudin, V. Vaudry et al., EFFECTS OF SEROTONIN AND VASOPRESSIN ON CORTISOL PRODUCTION FROM AN ADRENOCORTICAL TUMOR CAUSING SUBCLINICAL CUSHING'S SYNDROME, Endocrine Research, vol.58, issue.4, pp.787-91, 2002.
DOI : 10.1038/365170a0

V. Contesse, Y. Reznik, E. Louiset, C. Duparc, D. Cartier et al., Studies, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.5, pp.2843-50, 2005.
DOI : 10.1210/jc.2004-2476

?. Cortez, V. Santana, M. Marques, A. Mota, A. Rosmaninho-salgado et al., Regulation of catecholamine release in human adrenal chromaffin cells by ?adrenoceptors, Neurochem Int. 2012, vol.60, issue.4, 2012.

?. Côté, M. Guillon, G. Payet, M. Gallo-payet, and N. , Expression and Regulation of Adenylyl Cyclase Isoforms in the Human Adrenal Gland, Journal of Clinical Endocrinology & Metabolism, vol.86, issue.9, 2001.
DOI : 10.1210/jc.86.9.4495

?. D-'arienzo, A. Ambrogio, G. , D. Siervi, P. Perna et al., A randomized comparison of metoclopramide and domperidone on plasma aldosterone concentration and on spironolactone-induced diuresis in ascitic cirrhotic patients. Hepatology, pp.854-861, 1985.

C. Delarue, D. Becquet, S. Idres, F. Hery, and H. Vaudry, Serotonin synthesis in adrenochromaffin cells, Neuroscience, vol.46, issue.2, pp.495-500, 1992.
DOI : 10.1016/0306-4522(92)90069-E

C. Delarue, V. Contesse, S. Lenglet, F. Sicard, V. Perraudin et al., Role of neurotransmitters and neuropeptides in the regulation of the adrenal cortex, Reviews in Endocrine and Metabolic Disorders, vol.2, issue.3, pp.253-67, 2001.
DOI : 10.1023/A:1011512415497

C. Delarue, J. Conlon, R. , I. Fournier, A. Vaudry et al., Endothelins as local activators of adrenocortical cells, Journal of Molecular Endocrinology, vol.32, issue.1, pp.1-7, 2004.
DOI : 10.1677/jme.0.0320001

?. Ehrhart-bornstein, M. Hinson, J. Bornstein, S. Scherbaum, W. Vinson et al., Intraadrenal Interactions in the Regulation of Adrenocortical Steroidogenesis, Endocrine Reviews, vol.19, issue.2, pp.101-144, 1998.
DOI : 10.1210/edrv.19.2.0326

?. Ehrhart-bornstein, M. Haidan, A. Alesci, S. Bornstein, and S. , Neurotransmitters and Neuropeptides in the Differential Regulation of Steroidogenesis in Adrenocortical-Chromaffin Co-Cultures, Endocrine Research, vol.129, issue.4, pp.833-875, 2000.
DOI : 10.1159/000124182

?. Evrard, A. Hober, C. Racadot, A. Lefebvre, J. Vantyghem et al., Hormone natriurétique auriculaire et fonctions endocrines, Ann Biol Clin, vol.57, issue.2, pp.149-55, 1999.

?. Fallo, F. Veglio, F. Bertello, C. Sonino, N. et al., Prevalence and Characteristics of the Metabolic Syndrome in Primary Aldosteronism, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.2, pp.454-463, 2006.
DOI : 10.1210/jc.2005-1733

?. Freel, E. Mark, P. Weir, R. Mcquarrie, E. Allan et al., Demonstration of Blood Pressure-Independent Noninfarct Myocardial Fibrosis in Primary Aldosteronism: A Cardiac Magnetic Resonance Imaging Study, Circulation: Cardiovascular Imaging, vol.5, issue.6, pp.740-747, 2012.
DOI : 10.1161/CIRCIMAGING.112.974576

?. García-iglesias, B. Mendoza-garrido, M. Gutiérrez-ospina, G. Rangel-barajas, C. Noyola-díaz et al., Sensitization of restraint-induced corticosterone secretion after chronic restraint in rats: Involvement of 5-HT7 receptors, Neuropharmacology, vol.71, pp.216-243, 2013.
DOI : 10.1016/j.neuropharm.2013.03.013

?. Geller, D. Zhang, J. Wisgerhof, M. Shackleton, C. Kashgarian et al., A Novel Form of Human Mendelian Hypertension Featuring Nonglucocorticoid-Remediable Aldosteronism, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.8, pp.3117-3140, 2008.
DOI : 10.1210/jc.2008-0594

?. Ghosh, S. Smriga, M. Vuvor, F. Suri, D. Mohammed et al., Effect of lysine supplementation on health and morbidity in subjects belonging to poor peri-urban households in Accra, Ghana, American Journal of Clinical Nutrition, vol.92, issue.4, pp.928-967, 2009.
DOI : 10.3945/ajcn.2009.28834

?. Guillemot, J. Compagnon, P. Cartier, D. Thouennon, E. Bastard et al., Metoclopramide stimulates catecholamine- and granin-derived peptide secretion from pheochromocytoma cells through activation of serotonin type 4 (5-HT4) receptors, Endocrine Related Cancer, vol.16, issue.1, pp.281-290, 2009.
DOI : 10.1677/ERC-08-0190

?. Hegde, S. Eglen, and R. , Peripheral 5-HT4 receptors, FASEB J, vol.10, issue.12, pp.1398-407, 1996.

J. Hinson, G. Vinson, J. Pudney, and B. Whitehouse, Adrenal mast cells modulate vascular and secretory responses in the intact adrenal gland of the rat, Journal of Endocrinology, vol.121, issue.2, pp.253-60, 1989.
DOI : 10.1677/joe.0.1210253

?. Kidambi, S. Kotchen, J. Grim, C. Raff, H. Mao et al., Association of Adrenal Steroids With Hypertension and the Metabolic Syndrome in Blacks, Hypertension, vol.49, issue.3, pp.704-715, 2007.
DOI : 10.1161/01.HYP.0000253258.36141.c7

?. Lampron, A. Bourdeau, I. Oble, S. Godbout, A. Schürch et al., Regulation of Aldosterone Secretion by Several Aberrant Receptors Including for Glucose-Dependent Insulinotropic Peptide in a Patient with an Aldosteronoma, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.3, pp.750-756, 1340.
DOI : 10.1210/jc.2008-1340

?. Leboulenger, F. Benyamina, M. Delarue, C. Netchitaïlo, P. Saint-pierre et al., Neuronal and paracrine regulation of adrenal steroidogenesis: interactions between acetylcholine, serotonin and vasoactive intestinal peptide (VIP) on corticosteroid production by frog interrenal tissue, Brain Research, vol.453, issue.1-2, pp.103-112, 1988.
DOI : 10.1016/0006-8993(88)90147-3

H. Lefebvre, V. Contesse, C. Delarue, M. Feuilloley, F. Hery et al., Serotonin-induced stimulation of cortisol secretion from human adrenocortical tissue is mediated through activation of a serotonin4 receptor subtype, Neuroscience, vol.47, issue.4, pp.999-1007, 1992.
DOI : 10.1016/0306-4522(92)90047-6

H. Lefebvre, V. Contesse, C. Delarue, J. Kuhn, H. Vaudry et al., Lack of effect of the serotonin 4 receptor agonist zacopride on ACTH secretion in normal men, European Journal of Clinical Pharmacology, vol.51, issue.1, pp.49-51, 1996.
DOI : 10.1007/s002280050159

?. Mantero, F. Opocher, G. Boscaro, M. Armanini, and D. , Effect of serotonin on plasma aldosterone in man, Journal of Endocrinological Investigation, vol.1, issue.4, pp.97-106, 1982.
DOI : 10.1007/BF03350498

?. Mazzuco, T. Chaffanjon, P. Martinie, M. Sturm, N. Chabre et al., Adrenal Cushing???s Syndrome Due to Bilateral Macronodular Adrenal Hyperplasia: Prediction of the Efficacy of ??-blockade Therapy and Interest of Unilateral Adrenalectomy, Endocrine Journal, vol.56, issue.7, pp.867-77, 2009.
DOI : 10.1507/endocrj.K08E-370

M. Namara, B. Boyd, and G. , The role of lysine-rich proteins in the acute steroidogenic response of rat adrenal cells to ACTH, Biochemical and Biophysical Research Communications, vol.118, issue.2, pp.400-404, 1984.
DOI : 10.1016/0006-291X(84)91316-0

?. Mckelvie, R. Yusuf, S. Pericak, D. Avezum, A. Burns et al., Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure : Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study: The RESOLVD Pilot Study Investigators, Circulation, vol.100, issue.10, pp.1056-64, 1999.
DOI : 10.1161/01.CIR.100.10.1056

?. Milliez, P. Girerd, X. Plouin, P. Blacher, J. Safar et al., Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism, Journal of the American College of Cardiology, vol.45, issue.8, pp.1243-1251, 2005.
DOI : 10.1016/j.jacc.2005.01.015

?. Mulatero, P. Bertello, C. Rossato, D. Mengozzi, G. Milan et al., Roles of Clinical Criteria, Computed Tomography Scan, and Adrenal Vein Sampling in Differential Diagnosis of Primary Aldosteronism Subtypes, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.4, pp.1366-71, 2008.
DOI : 10.1210/jc.2007-2055

?. Mulatero, P. Stowasser, M. Loh, K. Fardella, C. Gordon et al., Increased Diagnosis of Primary Aldosteronism, Including Surgically Correctable Forms, in Centers from Five Continents, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.3, pp.1045-50, 2004.
DOI : 10.1210/jc.2003-031337

?. Nishimura, M. Uzu, T. Fujii, T. Kuroda, S. Nakamura et al., Cardiovascular complications in patients with primary aldosteronism, American Journal of Kidney Diseases, vol.33, issue.2, pp.261-267, 1999.
DOI : 10.1016/S0272-6386(99)70298-2

?. Nussdorfer and G. , Paracrine control of adrenal cortical function by medullary chromaffin cells, Pharmacol Rev, vol.48, issue.4, pp.495-530, 1996.

?. Oda, N. Takeda, Y. Zhu, A. Usukura, M. Yoneda et al., Pathophysiological Roles of the Adrenal Renin-Angiotensin System in Patients with Primary Aldosteronism, Hypertension Research, vol.29, issue.1, pp.9-14, 2006.
DOI : 10.1291/hypres.29.9

?. Perraudin, V. Delarue, C. Lefebvre, H. , D. Rego et al., Studies, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.4, pp.1566-72, 2006.
DOI : 10.1210/jc.2005-1453

?. Peters and J. , Local renin-angiotensin systems in the adrenal gland. Peptides, 2012.

?. Pitt, B. Zannad, F. Remme, W. Cody, R. Castaigne et al., The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure, New England Journal of Medicine, vol.341, issue.10, pp.709-726, 1999.
DOI : 10.1056/NEJM199909023411001

?. Pitt, B. Remme, W. Zannad, F. Neaton, J. Martinez et al., Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction, N Engl J Med, 2003.

B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez et al., Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction, New England Journal of Medicine, vol.348, issue.14, pp.1309-1330, 2003.
DOI : 10.1056/NEJMoa030207

?. Pivonello, R. Ferone, D. De-herder, W. De-krijger, R. Waaijers et al., Dopamine Receptor Expression and Function in Human Normal Adrenal Gland and Adrenal Tumors, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.9, pp.4493-502, 2004.
DOI : 10.1210/jc.2003-031746

?. Plouin, P. Amar, L. Chatellier, and G. , Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension, Nephrology Dialysis Transplantation, vol.19, issue.4, pp.774-781, 2004.
DOI : 10.1093/ndt/gfh112

?. Pompei, P. Riftina, F. Mcewen, and B. , Effect of adrenal steroids on preproneurokinin-A gene expression in discrete regions of the rat brain, Molecular Brain Research, vol.33, issue.2, 1995.
DOI : 10.1016/0169-328X(95)00115-9

?. Pouleur, A. Uno, H. Prescott, M. Desai, A. Appelbaum et al., Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension, Journal of the Renin-Angiotensin-Aldosterone System, vol.110, issue.4, pp.483-90, 2011.
DOI : 10.1177/147323000102900103

?. Reznik, Y. Lefebvre, H. Rohmer, V. Charbonnel, B. Tabarin et al., REHOS study group. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study, Clin Endocrinol, 2004.

?. Ritchie, P. Knight, H. Ashby, M. Judd, and A. , Serotonin increases interleukin-6 release and decreases tumor necrosis factor release from rat adrenal zona glomerulosa cells in vitro, Endocrine, vol.133, issue.3, pp.291-298, 1996.
DOI : 10.1007/BF02739062

?. Rizzi, C. Mierau, J. Ladinsky, and H. , Regulation of Plasma Aldosterone Levels by Metoclopramide: a Reappraisal of its Mechanism from Dopaminergic Antagonism to Serotonergic Agonism, Neuropharmacology, vol.36, issue.6, pp.763-771, 1997.
DOI : 10.1016/S0028-3908(97)00025-7

?. Rossi, G. Bernini, G. Desideri, G. Fabris, B. Ferri et al., Renal Damage in Primary Aldosteronism: Results of the PAPY Study, Hypertension, vol.48, issue.2, pp.232-240, 2006.
DOI : 10.1161/01.HYP.0000230444.01215.6a

?. Rossi, G. Bernini, G. Caliumi, C. Desideri, G. Fabris et al., A Prospective Study of the Prevalence of Primary Aldosteronism in 1,125 Hypertensive Patients, Journal of the American College of Cardiology, vol.48, issue.11, pp.2293-300, 2006.
DOI : 10.1016/j.jacc.2006.07.059

?. Rossi, G. Bolognesi, M. Rizzoni, D. Seccia, T. Piva et al., Vascular Remodeling and Duration of Hypertension Predict Outcome of Adrenalectomy in Primary Aldosteronism Patients, Hypertension, vol.51, issue.5, pp.1366-71, 2008.
DOI : 10.1161/HYPERTENSIONAHA.108.111369

?. Rossi, G. Auchus, R. Brown, M. Lenders, J. Naruse et al., An Expert Consensus Statement on Use of Adrenal Vein Sampling for the Subtyping of Primary Aldosteronism, Hypertension, vol.63, issue.1, pp.151-60
DOI : 10.1161/HYPERTENSIONAHA.113.02097

?. Rucinski, M. Ziolkowska, A. Tyczewska, M. Malendowicz, and L. , Expression of prepro-ghrelin and related receptor genes in the rat adrenal gland and evidences that ghrelin exerts a potent stimulating effect on corticosterone secretion by cultured rat adrenocortical cells, Peptides, vol.30, issue.8, pp.1448-55, 2009.
DOI : 10.1016/j.peptides.2009.04.016

?. Sata, Y. Krum, and H. , The Future of Pharmacological Therapy for Heart Failure, Circulation Journal, vol.74, issue.5, 2010.
DOI : 10.1253/circj.CJ-10-0272

?. Savard, S. Amar, L. Plouin, P. Steichen, and O. , Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study, Hypertension, vol.62, issue.2, p.2013
DOI : 10.1161/HYPERTENSIONAHA.113.01060

?. Sechi, L. , D. Fabio, A. Bazzocchi, M. Uzzau et al., Intrarenal Hemodynamics in Primary Aldosteronism before and after Treatment, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.4, 2009.
DOI : 10.1210/jc.2008-2245

?. Smriga, M. Torii, and K. , L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats, Proceedings of the National Academy of Sciences, vol.100, issue.26, pp.15370-15375, 2003.
DOI : 10.1073/pnas.2436556100

?. Smriga, M. Ghosh, S. Mouneimne, Y. Pellett, P. Scrimshaw et al., Lysine fortification reduces anxiety and lessens stress in family members in economically weak communities in Northwest Syria, Proceedings of the National Academy of Sciences, vol.101, issue.22, pp.8285-8293, 2004.
DOI : 10.1073/pnas.0402550101

?. Smriga, M. Ando, T. Akutsu, M. Furukawa, Y. Miwa et al., Oral treatment with L-lysine and L-arginine reduces anxiety and basal cortisol levels in healthy humans, Biomedical Research, vol.28, issue.2
DOI : 10.2220/biomedres.28.85

?. Sommers, D. Meyer, E. Van-wyk, M. De-villiers, and L. , Aldosterone response to metoclopramide is mediated through the autonomic nervous system in man, European Journal of Clinical Pharmacology, vol.50, issue.Suppl, pp.609-621, 1988.
DOI : 10.1007/BF00542496

?. Stowasser, M. Gordon, R. Rutherford, J. Nikwan, N. Daunt et al., Review: Diagnosis and management of primary aldosteronism, Journal of the Renin-Angiotensin-Aldosterone System, vol.3, issue.5, pp.156-69, 2001.
DOI : 10.3317/jraas.2001.022

?. Stowasser, M. Sharman, J. Leano, R. Gordon, R. Ward et al., Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I, J Clin Endocrinol Metab, 2005.

?. Suzuki, T. Abe, H. Nagata, S. Saitoh, F. Iwata et al., Left ventricular structural characteristics in unilateral renovascular hypertension and primary aldosteronism, The American Journal of Cardiology, vol.62, issue.17, pp.1224-1231, 1988.
DOI : 10.1016/0002-9149(88)90264-0

?. Tsurugizawa, T. Uematsu, A. Uneyama, H. Torii, and K. , Reversible brain response to an intragastric load of l-lysine under l-lysine depletion in conscious rats, British Journal of Nutrition, vol.67, issue.07, 2013.
DOI : 10.1053/j.gastro.2009.02.057

?. Vasan, R. Evans, J. Larson, M. Wilson, P. Meigs et al., Serum Aldosterone and the Incidence of Hypertension in Nonhypertensive Persons, New England Journal of Medicine, vol.351, issue.1, pp.33-41, 2004.
DOI : 10.1056/NEJMoa033263

D. Vezzosi, D. Cartier, C. Régnier, P. Otal, A. Bennet et al., Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors, European Journal of Endocrinology, vol.156, issue.1, pp.21-31, 2007.
DOI : 10.1530/eje.1.02324

?. Wu, K. Chen, Y. Chu, T. Chueh, S. Wu et al., Expression and Localization of Human Dopamine D2 and D4 Receptor mRNA in the Adrenal Gland, Aldosterone-Producing Adenoma, and Pheochromocytoma, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.9, pp.4460-4467, 2001.
DOI : 10.1210/jcem.86.9.7859

?. Yoshida, T. Mio, M. Tasaka, and K. , Cortisol secretion induced by substance p from bovine adrenocortical cells and its inhibition by calmodulin inhibitors, Biochemical Pharmacology, vol.43, issue.3, pp.513-520, 1992.
DOI : 10.1016/0006-2952(92)90572-Z

?. Young-jr and W. , Primary aldosteronism ??? treatment options, Growth Hormone & IGF Research, vol.13, 2003.
DOI : 10.1016/S1096-6374(03)00064-9

?. Young and W. , Primary aldosteronism: renaissance of a syndrome, Clinical Endocrinology, vol.131, issue.5
DOI : 10.1007/s10741-005-2345-1

?. Zennaro, M. Boulkroun, S. Fernandes-rosa, and F. , An update on novel mechanisms of primary aldosteronism, Journal of Endocrinology, vol.224, issue.2, pp.63-7714, 2015.
DOI : 10.1530/JOE-14-0597

?. Zhang, D. Gauthier, K. Falck, J. Siddam, A. Campbell et al., Steroid-Producing Cells Regulate Arterial Tone of Adrenal Cortical Arteries, Endocrinology, vol.148, issue.8, 2007.
DOI : 10.1210/en.2007-0169